Search

Subba R Katamreddy

age ~64

from Raleigh, NC

Also known as:
  • Subba Reddy Katamreddy
  • Subba V Katamreddy
  • Vijaya L Katamreddy
  • Subba Y
Phone and address:
9309 Teton Pines Way, Raleigh, NC 27617
9197681537

Subba Katamreddy Phones & Addresses

  • 9309 Teton Pines Way, Raleigh, NC 27617 • 9197681537 • 9198060736
  • 2133 Winter Walk Cir, Morrisville, NC 27560 • 9194630756
  • Atlanta, GA
  • Research Triangle Park, NC
  • 9309 Teton Pines Way, Raleigh, NC 27617 • 9198060736

Work

  • Position:
    Professional/Technical

Education

  • Degree:
    High school graduate or higher

Emails

Us Patents

  • Cycloalkylidene Compounds As Modulators Of Estrogen Receptor

    view source
  • US Patent:
    7569601, Aug 4, 2009
  • Filed:
    May 14, 2007
  • Appl. No.:
    11/748096
  • Inventors:
    Jing Fang - Durham NC, US
    Dennis Heyer - Durham NC, US
    Aaron Bayne Miller - Durham NC, US
    Frank Navas, III - Durham NC, US
    William J. Zuercher - Durham NC, US
    Subba Reddy Katamreddy - Durham NC, US
  • Assignee:
    SmithKline Beecham Corporation - Philadelphia PA
  • International Classification:
    A61K 31/351
    C07D 315/00
  • US Classification:
    514459, 549426
  • Abstract:
    The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
  • Naphthalene Compounds As Selective Estrogen Receptor Modulators

    view source
  • US Patent:
    7649093, Jan 19, 2010
  • Filed:
    Jun 21, 2005
  • Appl. No.:
    11/570838
  • Inventors:
    Dennis Heyer - Durham NC, US
    Jing Fang - Durham NC, US
    Frank Navas, III - Durham NC, US
    Subba Reddy Katamreddy - Durham NC, US
    Jennifer Poole Peckham - Durham NC, US
    Philip Stewart Turnbull - Durham NC, US
    Aaron Bayne Miller - Durham NC, US
    Adwoa Akwabi-Ameyaw - Durham NC, US
  • Assignee:
    Glaxo Smith Kline LLC - Wilmington DE
  • International Classification:
    C07D 471/00
    C07D 295/00
    A61K 31/445
  • US Classification:
    546 86, 514319, 544386
  • Abstract:
    The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.
  • Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators

    view source
  • US Patent:
    7723393, May 25, 2010
  • Filed:
    May 24, 2006
  • Appl. No.:
    11/915436
  • Inventors:
    Jing Fang - Durham NC, US
    Dennis Heyer - Durham NC, US
    Subba Reddy Katamreddy - Durham NC, US
    Kenneth William Batchelor - Durham NC, US
    Richard Dana Caldwell - Durham NC, US
  • Assignee:
    GlaxoSmithKline LLC - Philadelphia PA
  • International Classification:
    A01N 35/00
    C07D 309/00
  • US Classification:
    514683, 514754, 514766, 562468, 549356
  • Abstract:
    The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
  • Cycloalkylidene Compounds As Modulators Of Estrogen Receptor

    view source
  • US Patent:
    7799828, Sep 21, 2010
  • Filed:
    Jun 8, 2009
  • Appl. No.:
    12/480097
  • Inventors:
    Jing Fang - Durham NC, US
    Dennis Heyer - Durham NC, US
    Aaron Bayne Miller - Durham NC, US
    Frank Navas, III - Durham NC, US
    William J. Zuercher - Durham NC, US
    Subba Reddy Katamreddy - Durham NC, US
  • Assignee:
    GlaxoSmithKline LLC - Philadelphia PA
  • International Classification:
    A61K 31/351
  • US Classification:
    514459
  • Abstract:
    The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
  • Bicyclic Compounds And Use As Antidiabetics

    view source
  • US Patent:
    8101634, Jan 24, 2012
  • Filed:
    Dec 5, 2007
  • Appl. No.:
    12/517620
  • Inventors:
    Jing Fang - Durham NC, US
    Jun Tang - Durham NC, US
    Andrew J Carpenter - Durham NC, US
    Gregory Peckham - Durham NC, US
    Christopher R Conlee - Durham NC, US
    Kien S Du - Durham NC, US
    Subba Reddy Katamreddy - Durham NC, US
  • Assignee:
    GlaxoSmithKline LLC - Philadelphia PA
  • International Classification:
    A61K 31/424
    A61K 31/445
    C07D 401/14
    C07D 413/14
  • US Classification:
    514315, 546184
  • Abstract:
    The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
  • Chemical Compounds

    view source
  • US Patent:
    8222261, Jul 17, 2012
  • Filed:
    Jan 13, 2009
  • Appl. No.:
    12/373524
  • Inventors:
    Subba R Katamreddy - Durham NC, US
    Richard Dama Caldwell - Durham NC, US
    Dennis Heyer - Durham NC, US
    Vincente Samano - Durham NC, US
    James Benjamin Thompson - Durham NC, US
    Andrew J Carpenter - Durham NC, US
    Christopher R Conlee - Durham NC, US
    Eric Eugene Boros - Durham NC, US
    Brian D Thompson - Durham NC, US
  • Assignee:
    GlaxoSmithKline, LLC - Philadelphia PA
  • International Classification:
    A61K 31/519
  • US Classification:
    5142651
  • Abstract:
    The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
  • Novel Compounds

    view source
  • US Patent:
    20070111971, May 17, 2007
  • Filed:
    Oct 4, 2004
  • Appl. No.:
    10/575038
  • Inventors:
    John Eaddy - Durham NC, US
    Dennis Heyer - Durham NC, US
    Amarjit Randhawa - Durham NC, US
    Vicente Sanano - Durham NC, US
    John Ray - Durham NC, US
    Subba Katamreddy - Durham NC, US
    Michael Martin - Durham NC, US
    Michael McClure - Durham NC, US
  • International Classification:
    A61K 31/66
  • US Classification:
    514124000, 514568000
  • Abstract:
    Compounds of formula (I): with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.
  • Chemical Compounds

    view source
  • US Patent:
    20080234199, Sep 25, 2008
  • Filed:
    Nov 22, 2006
  • Appl. No.:
    12/094189
  • Inventors:
    Subba Reddy Katamreddy - Durham NC, US
  • International Classification:
    A61K 31/42
    C07C 59/52
    C07C 235/34
    C07D 261/08
    C07D 307/42
    C07D 231/12
    A61K 31/34
    A61K 38/27
    A61K 31/568
    A61P 3/00
    A61P 1/00
    A61P 35/00
    A61P 19/00
    A61K 31/566
    A61K 38/29
    A61K 38/25
    A61K 31/415
    C07C 43/23
    A61K 31/192
    A61K 31/165
    A61K 31/085
  • US Classification:
    514 12, 562468, 564171, 548247, 549502, 5483731, 568640, 514570, 514622, 514720, 514378, 514406, 514461, 514171
  • Abstract:
    Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.

Resumes

Subba Katamreddy Photo 1

President

view source
Location:
Raleigh, NC
Industry:
Pharmaceuticals
Work:
Vijaya Pharmaceuticals since Jan 2009
Scientific Advisor

GlaxoSmithKline Jul 2001 - Aug 2008
Principal Scientist & Research Investigator

Emory University Nov 1998 - Jun 2001
Post-Docotoral Fellow
Education:
Pondicherry University 1988 - 1994
Ph.D, Organic ChemistryThesis title: Studies in stereochemistry: Stereoselectivity in cyclic beta-ketoester alkylations and cyclic enone reductions.
Skills:
Synthetic Organic Chemistry
Medicinal Chemistry
Carbohydrate Chemistry
Asymmetric Synthesis
Innovative Problem Solver
Drug Discovery
Lead Generation and Lead Optimization
Metabolic Diseases
Drug Design
Pharmaceuticals
Subba Katamreddy Photo 2

Research Investigator

view source
Location:
Raleigh, NC
Industry:
Research
Work:
Gsk
Research Investigator
Subba Katamreddy Photo 3

President

view source
Location:
Raleigh, NC
Work:
Spv Therapeutics
President
Subba Katamreddy Photo 4

Scientific Advisor At Vijaya Pharmaceuticals

view source
Location:
Raleigh-Durham, North Carolina Area
Industry:
Pharmaceuticals
Name / Title
Company / Classification
Phones & Addresses
Subba R. Katamreddy
Chief Executive Officer
Vijaya Pharmaceuticals, Inc
Mfg Medicinal/Botanical Products
1515 Dickey Dr NE, Atlanta, GA 30322
Subba R. Katamreddy
Branch Manager
Vijaya Pharmacuticals
Business Services
9309 Teton Pne Way, Raleigh, NC 27617

Youtube

YSRCP MP YV Subba Reddy Wife Face to Face - W...

MP YV Subba Reddy Wife Face to Face | AP Special Status: 5 YSRCP MPs t...

  • Duration:
    1m

YV Subba reddy Before - After | TTD Chairman ...

TTD Chairman #YVSubba Reddy #Tirumala YV Subba reddy Before - After | ...

  • Duration:
    2m 17s

Allur katamreddy vishnuvardhanred... viral v...

Allur katamreddy vishnuvardhanred... viral video song rockstar channel.

  • Duration:
    4m 29s

Motivational Speaker Pokala SubbaReddy Exclus...

Motivational Speaker Pokala SubbaReddy Exclusive Interview | Pokala Su...

  • Duration:
    16m 58s

Yv Subba Reddy Controversial Comments On Bali...

YSRCP CP Ex MP #YvSubbaReddy Controversial Comments On Balineni Sriniv...

  • Duration:
    1m 39s

TDP Leader Redyam Venkata Subbareddy Fire On ...

TDP Leader Redyam Venkata Subbareddy Fire On YSRCP MLA Raghurami Reddy...

  • Duration:
    4m 31s

Kavali TDP Candidate Katamreddy Vishnuvardhan...

Kavali TDP Candidate Katamreddy Vishnuvardhan ReddyConstituenc... #Ka...

  • Duration:
    5m 30s

TTD Chairman YV Subba Reddy Inspects TTD Mark...

TTD Chairman YV Subba Reddy Inspects TTD Marketing Godown | hmtv #TTD ...

  • Duration:
    58s

Get Report for Subba R Katamreddy from Raleigh, NC, age ~64
Control profile